IPW
DXCM icon

Invictus Private Wealth’s DexCom DXCM Stock Holding History

Invictus Private Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,186
Closed -$361K – 85
2024
Q2 		$361K Sell
3,186
-177
-5% -$22.4K 0.03% 65
2024
Q1 		$466K Sell
3,363
-137
-4% -$17.2K 0.04% 54
2023
Q4 		$434K Sell
3,500
-148
-4% -$15.1K 0.04% 58
2023
Q3 		$340K Sell
3,648
-2
-0.1% -$225 0.04% 67
2023
Q2 		$469K Hold
3,650
– – 0.05% 55
2023
Q1 		$424K Hold
3,650
– – 0.05% 54
2022
Q4 		$413K Buy
+3,650
New +$401K 0.05% 54

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invictus Private Wealth's DXCM Position: Q3 2024 in Review

Invictus Private Wealth sold out of DexCom (DXCM) in Q3 2024, closing a stake of 3,186 shares — an estimated $361K sold.

Invictus Private Wealth first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $469K in Q2 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Invictus Private Wealth reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Invictus Private Wealth sold 3,186 DexCom shares in Q3 2024, an estimated $361K.
  • Invictus Private Wealth first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Invictus Private Wealth's DexCom position peaked at $469K in Q2 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Invictus Private Wealth's 13F filing for Q3 2024, filed 30 Oct 2024.